View Future GrowthDispensa Group 過去の業績過去 基準チェック /06Dispensa Groupの過去数年間の業績に関するデータが不十分です。主要情報n/a収益成長率n/aEPS成長率Consumer Retailing 業界の成長10.52%収益成長率n/a株主資本利益率-12.77%ネット・マージン-59.63%前回の決算情報28 Feb 2023最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdomお知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.お知らせ • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.Board Change • Oct 31Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.お知らせ • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.収支内訳Dispensa Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:K7L 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費28 Feb 234-33030 Nov 223-22031 Aug 222-120質の高い収益: K7Lは現在利益が出ていません。利益率の向上: K7Lは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: K7Lは株式公開されてから 3 年未満しか経っていないため、過去 5 年間の前年比収益成長率がプラスであったかどうかを判断できません。成長の加速: K7Lの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: K7Lは利益が出ていないため、過去 1 年間の収益成長をConsumer Retailing業界 ( 2.8% ) と比較することは困難です。株主資本利益率高いROE: K7Lは現在利益が出ていないため、自己資本利益率 ( -12.77% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YConsumer-retailing 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/03/21 09:13終値2024/03/21 00:00収益2023/02/28年間収益2022/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Dispensa Group Plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 19Dispensa Group Announces Cancellation of Trading of Ordinary Shares on the Main Market for Listed Securities of the London Stock ExchangeFurther to the announcements made on 16 February and 14 March 2024, Dispensa Group Plc announced that the listing of the company's Ordinary Shares on the Official List of the Financial Conduct Authority and admission to trading on the Main Market for listed securities of the London Stock Exchange plc have now been cancelled with effect from 8.00 a.m. (London time) 19 March 2024.
お知らせ • Feb 17Dispensa Group Plc, Annual General Meeting, Mar 14, 2024Dispensa Group Plc, Annual General Meeting, Mar 14, 2024, at 11:00 Coordinated Universal Time. Location: 50 Sloane Avenue, London SW3 3DD SW3 3DD London United Kingdom
お知らせ • Feb 14Dispensa Intends to Delist its Ordinary Shares from the U.K.'s Financial Conduct Authority's Official List, and Cancel its Listing on the London Stock ExchangeDispensa Group Plc said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel its listing on the London Stock Exchange. The e-commerce and retail technology company--formerly known as Zamaz--said the decision aims to maximize shareholder value and increase the company's potential for long-term success. The board said the challenges behind the implementation of its growth-acquisition strategy in a listed environment, the considerable management time and cost of remaining listed at this stage of the company's development, as well as current market conditions, were key factors behind the decision. The company also said that its strategy of buying undervalued, traditional premium brand businesses and digitizing their systems and processes to increase revenue, margins and value, is more suited to a private equity environment focusing "on longer-term initiatives, without the shorter-term reporting timelines of public equity markets." Dispensa said it will send out a circular setting out further details of the delisting, and its implications, by February 16. "The company also notes that the delisting would enable it to make numerous cost savings to the benefit of Shareholders and that it will implement a cost efficiency program should the delisting be approved," it said.
New Risk • Feb 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.92m (US$8.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€7.92m market cap, or US$8.53m). Minor Risk Latest financial reports are more than 6 months old (reported February 2023 fiscal period end).
New Risk • Jan 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (€18.6m market cap, or US$20.2m).
Buying Opportunity • Dec 16Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be €0.046, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Nov 23Dispensa Group Plc Announces Chief Executive Officer ChangesDispensa Group Plc announced that Mr. Alessandro Colombo is stepping down from his role as Chief Executive Officer for pressing personal reasons and has agreed with the Company that he will leave with immediate effect. Mr. Daniele Besnati has been re-appointed Interim Chief Executive Officer, a role he held immediately prior to Mr. Colombo's appointment. A further announcement regarding a new permanent appointment will be made in due course.
Board Change • Oct 31Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Chairman Niccolo Caderni was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 20Dispensa Group plc Appoints Alessandro Colombo as CEO with Immediate EffectDispensa Group plc announced the appointment of Mr. Alessandro Colombo as CEO with immediate effect. Mr. Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr. Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr. Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr. Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co. An Italian national, Mr. Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles. Mr. Colombo's current and past directorships are as follows: Past five years: Sonder Italy S.r.l., special attorney (legal representative) from December 10, 2018 until June 30, 2023 Director from October 28, 2019 until November 21, 2019.
お知らせ • Aug 24Zamaz plc Announces Board ChangesZamaz plc announced that Dr Niccolò Caderni, previously a Non-Executive Director of the Company, has been appointed Non-Executive Chairman with immediate effect. The previous Chairman, Martin Groak has moved to a Non-Executive Director role and remains as chairman of the Audit Committee.